Home » Industry Invited to Comment on EC Amendments to Licensing Regulation
Industry Invited to Comment on EC Amendments to Licensing Regulation
July 15, 2008
To cut through the red tape of what industry considers a burdensome regulation, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) wants public comment on the European Commission’s (EC) proposed changes to its centralized medicines legislation that deals with variations to licensed drugs.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor